Summary
The product Waklert 150 mg, manufactured by Sun Pharma, was analyzed to verify its active ingredient and potency. The sample was submitted and funded by Modawhale and tested by Janoshik Analytical, a laboratory specializing in pharmaceutical analysis. The analysis confirmed the presence of armodafinil at a measured concentration of 144.66 mg per tablet, reflecting a 3.56% variance below the labeled specification of 150 mg.
Testing was initiated on 31 October 2024, the sample was received on 5 November 2024, and the analysis was completed on 11 November 2024. The slight underdosing observed remains within acceptable limits, demonstrating consistency in manufacturing. However, given that the sample was submitted by the reseller, independent validation through market-acquired samples is advised to confirm batch consistency.
Detailed Report
Product Overview
- Manufacturer: Sun Pharma
- Product Name: Waklert 150 mg
- Active Ingredient: Armodafinil
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Oral tablet
Sample Acquisition and Testing
- Task Number: #52190
- Testing Ordered: 31 October 2024
- Sample Received: 5 November 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Modawhale (Reseller)
- Analysis Paid For By: Modawhale
Testing Results
- Specification: 150 mg (as stated on the label)
- Measured Concentration: 144.66 mg
- Accuracy: 96.44% (3.56% below the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/52190_TAG95ICQ171E
- Originally Published: https://thinksteroids.com/community/posts/3373596/
Evaluation of Reseller-Submitted Testing
The report highlights a minor variance of 3.56% below the labeled claim, demonstrating reliable dosing accuracy by Sun Pharma. However, since the sample was submitted and funded by the reseller, Modawhale, the possibility of selective sample submission exists. Resellers, like manufacturers, may choose to submit batches known to meet specifications. Cross-referencing with independently procured samples from the market would further strengthen confidence in the product’s consistency.
Conclusion
The analysis confirms that Waklert 150 mg is manufactured with reasonable dosing accuracy, showing only a 3.56% variance below the label claim. While this variance is acceptable, consumers should consider independent testing of market-acquired products to ensure consistent quality across batches. Such validation minimizes potential biases associated with reseller-submitted samples.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases due to selective sample submissions. The findings pertain solely to the tested batch and may not represent all products under the same name. Readers are encouraged to cross-reference these results with independent third-party testing for additional validation and use this information responsibly.
